BioCentury
ARTICLE | Company News

Ipsen, Vernalis deal

December 21, 2009 8:00 AM UTC

Vernalis will receive a $700,000 milestone payment from Ipsen under a 2008 deal in which Ipsen acquired Vernalis' U.S. subsidiary and U.S. rights to Vernalis' Apokyn apomorphine. The payment was trig...